
Fatigue cracks have been observed in the welded joints of end diaphragms in steel trough girder railway bridges. These fatigue cracks are thought to result from deterioration of the bridge supports and uneven settlements induced by train loads passing over them. As a simple repair method, crack-arrest holes are often drilled at the crack tips. However, their effectiveness remains unclear, and in some cases, the cracks tend to re-initiate and propagate. In this study, a fatigue test was conducted on an end diaphragm from a trough girder bridge under support conditions simulating those of an actual bridge. Crack propagation behavior and the effectiveness of the crack-arrest hole repair were examined through fatigue test and numerical analysis. In addition, finite element analysis replicating real bridge conditions was performed to clarify the effects of various parameters on the local stress at the edge of the crack-arrest hole. Furthermore, the effect of inserting a bolt into the hole on reducing the local stress at the hole edge was also investigated.
The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of December 2020 was searched in PubMed and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution Service (Minds) technique. A total of 38 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, pathological diagnosis deciding the diagnosis, and causal genes of vascular anomalies. Thus, the Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022 have been prepared as the evidence-based guidelines for the management of vascular anomalies.